Journal
BLOOD
Volume 117, Issue 14, Pages 3816-3825Publisher
AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2010-05-285064
Keywords
-
Categories
Funding
- Czech Ministries of Health [NS10310-3/2009, NT11218-6/2010]
Ask authors/readers for more resources
Elevated levels of microRNA miR-155 represent a candidate pathogenic factor in chronic B-lymphocytic leukemia (B-CLL). In this study, we present evidence that MYB (v-myb myeloblastosis viral oncogene homolog) is overexpressed in a subset of B-CLL patients. MYB physically associates with the promoter of miR-155 host gene (MIR155HG, also known as BIC, B-cell integration cluster) and stimulates its transcription. This coincides with the hypermethylated histone H3K4 residue and spread hyperacetylation of H3K9 at MIR155HG promoter. Our data provide evidence of oncogenic activities of MYB in B-CLL that include its stimulatory role in MIR155HG transcription. (Blood. 2011; 117(14):3816-3825)
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available